Ultragenyx Pharmaceutical is a mid-cap biotech firm with a promising pipeline and an optimistic outlook from analysts. Click ...

Orchard Therapeutics, a Kyowa Kirin company, today announced presentations from seven abstracts from across its hematopoietic stem cell (HSC) gene therapy portfolio will be featured at the 21st Annual ...

Isa Kujawski, a functional registered dietitian, explained that the period immediately following a workout is known as the ...

Cantor Fitzgerald upgraded shares of Beam Therapeutics (NASDAQ:BEAM – Free Report) from a neutral rating to an overweight rating in a research note published on Wednesday morning, Marketbeat reports.

along with its BEAM-302 base-editing candidate for alpha-1 antitrypsin deficiency (AATD) and BEAM-301, an in vivo lipid nanoparticle (LNP) therapy for glycogen storage disease 1a.

Increased Glycogen Storage: Creatine may boost glycogen (carbohydrate ... However, those with pre-existing conditions such as ...